XCSE
MONSO
Market cap2mUSD
Oct 07, Last price
0.25DKK
1D
-3.85%
1Q
-28.57%
IPO
-96.15%
Name
Monsenso A/S
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Monsenso A/S, established in Copenhagen, Denmark in 2013, specializes in developing and marketing digital health solutions for the treatment of mental disorders. The company offers a multi-faceted platform, including a dedicated Monsenso app for individuals, which assists users with self-assessments, questionnaires, sensor data collection from personal devices, medication and session reminders, visual progress tracking, motivational feedback, and psychoeducation incorporating cognitive behavioral therapy. A separate application is available for caregivers, providing self-assessment tools, questionnaires, educational content, and various learning resources. For healthcare professionals, Monsenso provides a clinical web portal designed for visualizing patient data, managing patient dashboards, reviewing historical overviews, conducting correlation analysis, facilitating secure messaging, supporting shared decision-making, and maintaining medical records. Additionally, clinicians have access to data analytics features, enabling the aggregation of historical health and behavioral data, statistical descriptions, analysis of correlations between behavior and illness progression, pattern identification, predictive mood forecasting, and risk assessment. The company's innovative tools are utilized by patients, their caregivers, clinical staff, healthcare systems, and researchers.
Headquarters & legal address
Rosenørns Alle 31, 2.
Frederiksberg, 84 1970
DK
Frederiksberg, 84 1970
DK
Previous name
MONSENSO ApS
Valuation
Title DKK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||